BACKGROUND: The goal of surgery for colorectal cancer is cure. Unfortunately post-operative mortality occurs. This study aims to identify co-morbidity and causes of mortality in the post-operative period in relation to direct technical complications of surgery. METHODS: All consecutive patients who underwent surgery for colorectal cancer were included. Co-morbidity was determined via the Charlson co-morbidity score. The post-operative course was studied and cause of death within 30 days was determined. Patients were divided in two groups: group 1 died within 30 days after surgery and group 2 survived for longer than 30 days. RESULTS: Twenty three out of 333 patients (6.9%) with colon cancer and 6 out of 112 (5.3%) with rectal cancer died in the post-operative period. Patients in group 1 were significantly older than patients in group 2 (P<0.001). Patients in group 1 with colon cancer also significantly had more often a higher stage of cancer (P=0.03). The Charlson co-morbidity score for patients with colon cancer in group 1 was mean 5.17 (SD 1.57, range, 1-8), and for rectal cancer mean 4.83 (SD 2.32, range, 2-7). There was no difference in Charlson co-morbidity score when patients from groups 1 and 2 were compared. In group 1, 13 (44%) died as a direct consequence of technical surgical complications. Sixteen patients died due to complications because of pre-existing co-morbidity. CONCLUSIONS: Post-operative mortality very often is the direct result of pre-existing co-morbidity and not always the direct result of the surgical procedure.
BACKGROUND: The goal of surgery for colorectal cancer is cure. Unfortunately post-operative mortality occurs. This study aims to identify co-morbidity and causes of mortality in the post-operative period in relation to direct technical complications of surgery. METHODS: All consecutive patients who underwent surgery for colorectal cancer were included. Co-morbidity was determined via the Charlson co-morbidity score. The post-operative course was studied and cause of death within 30 days was determined. Patients were divided in two groups: group 1 died within 30 days after surgery and group 2 survived for longer than 30 days. RESULTS: Twenty three out of 333 patients (6.9%) with colon cancer and 6 out of 112 (5.3%) with rectal cancer died in the post-operative period. Patients in group 1 were significantly older than patients in group 2 (P<0.001). Patients in group 1 with colon cancer also significantly had more often a higher stage of cancer (P=0.03). The Charlson co-morbidity score for patients with colon cancer in group 1 was mean 5.17 (SD 1.57, range, 1-8), and for rectal cancer mean 4.83 (SD 2.32, range, 2-7). There was no difference in Charlson co-morbidity score when patients from groups 1 and 2 were compared. In group 1, 13 (44%) died as a direct consequence of technical surgical complications. Sixteen patients died due to complications because of pre-existing co-morbidity. CONCLUSIONS: Post-operative mortality very often is the direct result of pre-existing co-morbidity and not always the direct result of the surgical procedure.
Authors: Daniel Henneman; Annelotte C M van Bommel; Alexander Snijders; Heleen S Snijders; Rob A E M Tollenaar; Michel W J M Wouters; Marta Fiocco Journal: Ann Surg Date: 2014-05 Impact factor: 12.969
Authors: Eva J A Morris; Elizabeth F Taylor; James D Thomas; Philip Quirke; Paul J Finan; Michel P Coleman; Bernard Rachet; David Forman Journal: Gut Date: 2011-04-12 Impact factor: 23.059
Authors: Yajun Yu; Megan Carey; William Pollett; Jane Green; Elizabeth Dicks; Patrick Parfrey; Yildiz E Yilmaz; Sevtap Savas Journal: BMC Med Date: 2019-07-29 Impact factor: 8.775
Authors: Sina Vatandoust; David Wattchow; Luigi Sposato; Michael Z Michael; John Leung; Kirsten Gormly; Gang Chen; Erin L Symonds; Jeanne Tie; Lito Electra Papanicolas; Susan Woods; Val Gebski; Kelly Mead; Aleksandra Kuruni; Christos S Karapetis Journal: BMC Cancer Date: 2022-03-01 Impact factor: 4.430
Authors: Rebecca J Birch; John C Taylor; Amy Downing; Katie Spencer; Paul J Finan; Riccardo A Audisio; Christopher M Carrigan; Peter J Selby; Eva J A Morris Journal: Eur J Surg Oncol Date: 2019-01-07 Impact factor: 4.424
Authors: Francisco Carrasco-Peña; Eloisa Bayo-Lozano; Miguel Rodríguez-Barranco; Dafina Petrova; Rafael Marcos-Gragera; Maria Carmen Carmona-Garcia; Josep Maria Borras; Maria-José Sánchez Journal: Int J Environ Res Public Health Date: 2020-09-14 Impact factor: 3.390